Raymond Debbane, a director at Lexicon Pharmaceuticals ($LXRX), made seven open market purchases of company shares over the past year, totaling about $723,000. His most recent buy was on February 25, 2026. These purchases rank him 675th among 4,983 insiders by dollar amount, compared to an average of $1.46 million per insider and 3.29 transactions. Debbane reported no open market sales in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 25, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | P | Common Stock | 2000 | $1.49 | 51,660,909.0000 | 365,780,799 | 0.00% | 0.00% |
| Feb. 23, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | P | Common Stock | 100000 | $1.47 | 51,658,909.0000 | 365,780,799 | 0.19% | 0.03% |
| Feb. 20, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | P | Common Stock | 100000 | $1.48 | 51,558,909.0000 | 365,780,799 | 0.19% | 0.03% |
| Feb. 19, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | P | Common Stock | 50000 | $1.44 | 51,458,909.0000 | 365,780,799 | 0.10% | 0.01% |
| Feb. 13, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | P | Common Stock | 57952 | $1.31 | 51,198,364.0000 | 365,780,799 | 0.11% | 0.02% |
| Feb. 17, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | P | Common Stock | 76857 | $1.31 | 51,275,221.0000 | 365,780,799 | 0.15% | 0.02% |
| Feb. 18, 2026 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | P | Common Stock | 133688 | $1.32 | 51,408,909.0000 | 365,780,799 | 0.26% | 0.04% |
| June 3, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | A | Stock Option (Right to Buy) | 103806 | $0.00 | 103,806.0000 | 363,020,303 | 9999.99% | 0.03% |
| June 3, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | A | Restricted Stock Units | 89312 | $0.00 | 89,312.0000 | 363,020,303 | 9999.99% | 0.02% |
| May 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | M | Common Stock | 36810 | $0.00 | 45,755,796.0000 | 363,020,303 | 0.08% | 0.01% |
| May 13, 2025 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | M | Restricted Stock Units | 36810 | $0.00 | 0.0000 | 363,020,303 | 100.00% | 0.01% |
| May 13, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | A | Stock Option (Right to Buy) | 44906 | $0.00 | 44,906.0000 | 0 | 9999.99% | 0.00% |
| May 13, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | A | Restricted Stock Units | 36810 | $0.00 | 36,810.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | M | Common Stock | 8032 | $0.00 | 6,800,083.0000 | 0 | 0.12% | 0.00% |
| April 28, 2024 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | M | Restricted Stock Units | 8032 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 11, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | P | Common Stock | 342874 | $1.08 | 6,643,231.0000 | 0 | 5.44% | 0.00% |
| Oct. 12, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | P | Common Stock | 148820 | $1.03 | 6,792,051.0000 | 0 | 2.24% | 0.00% |
| Oct. 10, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | P | Common Stock | 508306 | $1.14 | 6,300,357.0000 | 0 | 8.78% | 0.00% |
| May 21, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | M | Common Stock | 9302 | $0.00 | 5,792,051.0000 | 0 | 0.16% | 0.00% |
| May 21, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | M | Restricted Stock Units | 9302 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| May 9, 2023 | WW INTERNATIONAL, INC. | $WW | DEBBANE RAYMOND | Other | A | Common Stock | 835 | $0.00 | 134,387.0000 | 70,321,000 | 0.63% | 0.00% |
| April 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | A | Stock Option (Right to Buy) | 12658 | $0.00 | 12,658.0000 | 0 | 9999.99% | 0.00% |
| April 28, 2023 | LEXICON PHARMACEUTICALS, INC. | $LXRX | DEBBANE RAYMOND | Director | A | Restricted Stock Units | 8032 | $0.00 | 8,032.0000 | 0 | 9999.99% | 0.00% |
| April 3, 2023 | WW INTERNATIONAL, INC. | $WW | DEBBANE RAYMOND | Director | A | Common Stock | 2053 | $0.00 | 133,552.0000 | 70,321,000 | 1.56% | 0.00% |
| Jan. 2, 2023 | WW INTERNATIONAL, INC. | $WW | DEBBANE RAYMOND | Director | A | Common Stock | 5067 | $0.00 | 131,499.0000 | 70,321,000 | 4.01% | 0.01% |